Beta Bionics, Inc. · NASDAQ:BBNX
The Vanguard Group reported a 5.09% stake in Beta Bionics, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Oct 30, 2025
The Vanguard Group reported a 5.09% stake in Beta Bionics, Inc., 2,216,185 shares, as a passive investor on Sep 30, 2025. Filed Oct 30, 2025 (Schedule 13G).
- Stake
- 5.09%
- Shares
- 2,216,185
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.09% | 2,216,185 |
Source
Related
- Beta Bionics, Inc.
- The Vanguard Group
- Beta Bionics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Form 4 · Hopman Mark · Oct 16, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Oct 7, 2026
- Form 4 · Hopman Mark · Oct 5, 2026
- Form 4 · Jones Christy · Sep 23, 2026
- Form 4/A · Hopman Mark · Sep 18, 2026